PDCD4 and breast carcinoma: miR-21 is a well-studied oncomiR with anti-cancer targets, like PDCD4 [33], TIMP3 [34], and PTEN [35], and is overexpressed in human breast cancer tissues as compared to healthy breast tissues [34, 36].